0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Classical Swine Fever Vaccines Market Outlook 2022
Published Date: December 2021
|
Report Code: QYRE-Auto-4167
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Classical Swine Fever Vaccines Market Outlook 2022

Global Classical Swine Fever Vaccines Market Outlook 2022

Code: QYRE-Auto-4167
Report
December 2021
Pages:120
QYResearch
Description
Table of Content
Tables & Figures
It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
The global classical swine fever vaccine market is dominated by Winsun, Merial and CAHIC, with the top three manufacturers accounting for about 60% of the market share. Asia Pacific is the largest market for classical swine fever vaccines, with a market share of about 50%, followed by Europe with a market share of about 25%. Tissue Culture Origin is the main type, with a share about 60%. Market Sales is the main application, which holds a share about 95%.

The global Classical Swine Fever Vaccines market was valued at US$ 168 million in 2020 and is expected to reach US$ 245.4 million by the end of 2027, growing at a CAGR of 5.5% during 2021-2027.

This report focuses on Classical Swine Fever Vaccines volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Classical Swine Fever Vaccines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Classical Swine Fever Vaccines Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Source
Tissue Culture Origin
Cell Line Origin
Segment by Sales Channel
Government Tender
Market Sales

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

BY COMPANY

WINSUN
Merial
CAHIC
Chopper Biology
MSD Animal Health (Merck)
ChengDu Tecbond
Ceva
Harbin Veterinary Research Institute
Qilu Animal Health Products Factory
Ringpu Biology
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
1 Classical Swine Fever Vaccines Market Overview
1.1 Product Overview and Scope of Classical Swine Fever Vaccines
1.2 Classical Swine Fever Vaccines Segment by Source
1.2.1 Global Classical Swine Fever Vaccines Sales Growth Rate Comparison by Source (2021-2027)
1.2.2 Tissue Culture Origin
1.2.3 Cell Line Origin
1.3 Classical Swine Fever Vaccines Segment by Sales Channel
1.3.1 Global Classical Swine Fever Vaccines Sales Comparison by Sales Channel: (2021-2027)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Classical Swine Fever Vaccines Market Size Estimates and Forecasts
1.4.1 Global Classical Swine Fever Vaccines Revenue 2016-2027
1.4.2 Global Classical Swine Fever Vaccines Sales 2016-2027
1.4.3 Classical Swine Fever Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027
2 Classical Swine Fever Vaccines Market Competition by Manufacturers
2.1 Global Classical Swine Fever Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Classical Swine Fever Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Classical Swine Fever Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Classical Swine Fever Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Classical Swine Fever Vaccines Market Competitive Situation and Trends
2.5.1 Classical Swine Fever Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Classical Swine Fever Vaccines Players Market Share by Revenue
2.5.3 Global Classical Swine Fever Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Classical Swine Fever Vaccines Retrospective Market Scenario by Region
3.1 Global Classical Swine Fever Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Classical Swine Fever Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Classical Swine Fever Vaccines Market Facts & Figures by Country
3.3.1 North America Classical Swine Fever Vaccines Sales by Country
3.3.2 North America Classical Swine Fever Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Classical Swine Fever Vaccines Market Facts & Figures by Country
3.4.1 Europe Classical Swine Fever Vaccines Sales by Country
3.4.2 Europe Classical Swine Fever Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Classical Swine Fever Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Classical Swine Fever Vaccines Sales by Region
3.5.2 Asia Pacific Classical Swine Fever Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Classical Swine Fever Vaccines Market Facts & Figures by Country
3.6.1 Latin America Classical Swine Fever Vaccines Sales by Country
3.6.2 Latin America Classical Swine Fever Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Classical Swine Fever Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Classical Swine Fever Vaccines Sales by Country
3.7.2 Middle East and Africa Classical Swine Fever Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Classical Swine Fever Vaccines Historic Market Analysis by Source
4.1 Global Classical Swine Fever Vaccines Sales Market Share by Source (2016-2021)
4.2 Global Classical Swine Fever Vaccines Revenue Market Share by Source (2016-2021)
4.3 Global Classical Swine Fever Vaccines Price by Source (2016-2021)
5 Global Classical Swine Fever Vaccines Historic Market Analysis by Sales Channel
5.1 Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2016-2021)
5.2 Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2016-2021)
5.3 Global Classical Swine Fever Vaccines Price by Sales Channel (2016-2021)
6 Key Companies Profiled
6.1 WINSUN
6.1.1 WINSUN Corporation Information
6.1.2 WINSUN Description and Business Overview
6.1.3 WINSUN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 WINSUN Classical Swine Fever Vaccines Product Portfolio
6.1.5 WINSUN Recent Developments/Updates
6.2 Merial
6.2.1 Merial Corporation Information
6.2.2 Merial Description and Business Overview
6.2.3 Merial Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merial Classical Swine Fever Vaccines Product Portfolio
6.2.5 Merial Recent Developments/Updates
6.3 CAHIC
6.3.1 CAHIC Corporation Information
6.3.2 CAHIC Description and Business Overview
6.3.3 CAHIC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 CAHIC Classical Swine Fever Vaccines Product Portfolio
6.3.5 CAHIC Recent Developments/Updates
6.4 Chopper Biology
6.4.1 Chopper Biology Corporation Information
6.4.2 Chopper Biology Description and Business Overview
6.4.3 Chopper Biology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Chopper Biology Classical Swine Fever Vaccines Product Portfolio
6.4.5 Chopper Biology Recent Developments/Updates
6.5 MSD Animal Health (Merck)
6.5.1 MSD Animal Health (Merck) Corporation Information
6.5.2 MSD Animal Health (Merck) Description and Business Overview
6.5.3 MSD Animal Health (Merck) Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 MSD Animal Health (Merck) Classical Swine Fever Vaccines Product Portfolio
6.5.5 MSD Animal Health (Merck) Recent Developments/Updates
6.6 ChengDu Tecbond
6.6.1 ChengDu Tecbond Corporation Information
6.6.2 ChengDu Tecbond Description and Business Overview
6.6.3 ChengDu Tecbond Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 ChengDu Tecbond Classical Swine Fever Vaccines Product Portfolio
6.6.5 ChengDu Tecbond Recent Developments/Updates
6.7 Ceva
6.6.1 Ceva Corporation Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ceva Classical Swine Fever Vaccines Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Harbin Veterinary Research Institute
6.8.1 Harbin Veterinary Research Institute Corporation Information
6.8.2 Harbin Veterinary Research Institute Description and Business Overview
6.8.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product Portfolio
6.8.5 Harbin Veterinary Research Institute Recent Developments/Updates
6.9 Qilu Animal Health Products Factory
6.9.1 Qilu Animal Health Products Factory Corporation Information
6.9.2 Qilu Animal Health Products Factory Description and Business Overview
6.9.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product Portfolio
6.9.5 Qilu Animal Health Products Factory Recent Developments/Updates
6.10 Ringpu Biology
6.10.1 Ringpu Biology Corporation Information
6.10.2 Ringpu Biology Description and Business Overview
6.10.3 Ringpu Biology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Ringpu Biology Classical Swine Fever Vaccines Product Portfolio
6.10.5 Ringpu Biology Recent Developments/Updates
6.11 DHN
6.11.1 DHN Corporation Information
6.11.2 DHN Classical Swine Fever Vaccines Description and Business Overview
6.11.3 DHN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.11.4 DHN Classical Swine Fever Vaccines Product Portfolio
6.11.5 DHN Recent Developments/Updates
6.12 CAVAC
6.12.1 CAVAC Corporation Information
6.12.2 CAVAC Classical Swine Fever Vaccines Description and Business Overview
6.12.3 CAVAC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.12.4 CAVAC Classical Swine Fever Vaccines Product Portfolio
6.12.5 CAVAC Recent Developments/Updates
6.13 Komipharm
6.13.1 Komipharm Corporation Information
6.13.2 Komipharm Classical Swine Fever Vaccines Description and Business Overview
6.13.3 Komipharm Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Komipharm Classical Swine Fever Vaccines Product Portfolio
6.13.5 Komipharm Recent Developments/Updates
6.14 Agrovet
6.14.1 Agrovet Corporation Information
6.14.2 Agrovet Classical Swine Fever Vaccines Description and Business Overview
6.14.3 Agrovet Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Agrovet Classical Swine Fever Vaccines Product Portfolio
6.14.5 Agrovet Recent Developments/Updates
6.15 Bioveta
6.15.1 Bioveta Corporation Information
6.15.2 Bioveta Classical Swine Fever Vaccines Description and Business Overview
6.15.3 Bioveta Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Bioveta Classical Swine Fever Vaccines Product Portfolio
6.15.5 Bioveta Recent Developments/Updates
6.16 Jinyu Bio-Technology
6.16.1 Jinyu Bio-Technology Corporation Information
6.16.2 Jinyu Bio-Technology Classical Swine Fever Vaccines Description and Business Overview
6.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Product Portfolio
6.16.5 Jinyu Bio-Technology Recent Developments/Updates
6.17 Institutul Pasteur
6.17.1 Institutul Pasteur Corporation Information
6.17.2 Institutul Pasteur Classical Swine Fever Vaccines Description and Business Overview
6.17.3 Institutul Pasteur Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Institutul Pasteur Classical Swine Fever Vaccines Product Portfolio
6.17.5 Institutul Pasteur Recent Developments/Updates
6.18 MVP
6.18.1 MVP Corporation Information
6.18.2 MVP Classical Swine Fever Vaccines Description and Business Overview
6.18.3 MVP Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.18.4 MVP Classical Swine Fever Vaccines Product Portfolio
6.18.5 MVP Recent Developments/Updates
6.19 Tecon
6.19.1 Tecon Corporation Information
6.19.2 Tecon Classical Swine Fever Vaccines Description and Business Overview
6.19.3 Tecon Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Tecon Classical Swine Fever Vaccines Product Portfolio
6.19.5 Tecon Recent Developments/Updates
7 Classical Swine Fever Vaccines Manufacturing Cost Analysis
7.1 Classical Swine Fever Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Classical Swine Fever Vaccines
7.4 Classical Swine Fever Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Classical Swine Fever Vaccines Distributors List
8.3 Classical Swine Fever Vaccines Customers
9 Classical Swine Fever Vaccines Market Dynamics
9.1 Classical Swine Fever Vaccines Industry Trends
9.2 Classical Swine Fever Vaccines Growth Drivers
9.3 Classical Swine Fever Vaccines Market Challenges
9.4 Classical Swine Fever Vaccines Market Restraints
10 Global Market Forecast
10.1 Classical Swine Fever Vaccines Market Estimates and Projections by Source
10.1.1 Global Forecasted Sales of Classical Swine Fever Vaccines by Source (2022-2027)
10.1.2 Global Forecasted Revenue of Classical Swine Fever Vaccines by Source (2022-2027)
10.2 Classical Swine Fever Vaccines Market Estimates and Projections by Sales Channel
10.2.1 Global Forecasted Sales of Classical Swine Fever Vaccines by Sales Channel (2022-2027)
10.2.2 Global Forecasted Revenue of Classical Swine Fever Vaccines by Sales Channel (2022-2027)
10.3 Classical Swine Fever Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Classical Swine Fever Vaccines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Classical Swine Fever Vaccines by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
    Table 1. Global Classical Swine Fever Vaccines Sales (M Doses) Growth Rate Comparison by Source (2021-2027)
    Table 2. Global Classical Swine Fever Vaccines Sales (M Doses) Comparison by Sales Channel (2021-2027)
    Table 3. Global Classical Swine Fever Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Classical Swine Fever Vaccines Covered in This Study
    Table 5. Global Classical Swine Fever Vaccines Sales (M Doses) of Key Manufacturers (2016-2021)
    Table 6. Global Classical Swine Fever Vaccines Sales Market Share by Manufacturers (2016-2021)
    Table 7. Global Classical Swine Fever Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Classical Swine Fever Vaccines Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Classical Swine Fever Vaccines Average Price (US$/K Doses) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Classical Swine Fever Vaccines Manufacturing Sites and Area Served
    Table 11. Manufacturers Classical Swine Fever Vaccines Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Classical Swine Fever Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Classical Swine Fever Vaccines as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Classical Swine Fever Vaccines Sales by Region (2016-2021) & (M Doses)
    Table 16. Global Classical Swine Fever Vaccines Sales Market Share by Region (2016-2021)
    Table 17. Global Classical Swine Fever Vaccines Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Classical Swine Fever Vaccines Sales by Country (2016-2021) & (M Doses)
    Table 19. North America Classical Swine Fever Vaccines Sales Market Share by Country (2016-2021)
    Table 20. North America Classical Swine Fever Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Classical Swine Fever Vaccines Revenue Market Share by Country (2016-2021)
    Table 22. Europe Classical Swine Fever Vaccines Sales by Country (2016-2021) & (M Doses)
    Table 23. Europe Classical Swine Fever Vaccines Sales Market Share by Country (2016-2021)
    Table 24. Europe Classical Swine Fever Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Classical Swine Fever Vaccines Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Classical Swine Fever Vaccines Sales by Region (2016-2021) & (M Doses)
    Table 27. Asia Pacific Classical Swine Fever Vaccines Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Classical Swine Fever Vaccines Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Classical Swine Fever Vaccines Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Classical Swine Fever Vaccines Sales by Country (2016-2021) & (M Doses)
    Table 31. Latin America Classical Swine Fever Vaccines Sales Market Share by Country (2016-2021)
    Table 32. Latin America Classical Swine Fever Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Classical Swine Fever Vaccines Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2016-2021) & (M Doses)
    Table 35. Middle East and Africa Classical Swine Fever Vaccines Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Classical Swine Fever Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Classical Swine Fever Vaccines Revenue Market Share by Country (2016-2021)
    Table 38. Global Classical Swine Fever Vaccines Sales (M Doses) by Source (2016-2021)
    Table 39. Global Classical Swine Fever Vaccines Sales Market Share by Source (2016-2021)
    Table 40. Global Classical Swine Fever Vaccines Revenue (Million US$) by Source (2016-2021)
    Table 41. Global Classical Swine Fever Vaccines Revenue Share by Source (2016-2021)
    Table 42. Global Classical Swine Fever Vaccines Price (US$/K Doses) by Source (2016-2021)
    Table 43. Global Classical Swine Fever Vaccines Sales (M Doses) by Sales Channel (2016-2021)
    Table 44. Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2016-2021)
    Table 45. Global Classical Swine Fever Vaccines Revenue (Million US$) by Sales Channel (2016-2021)
    Table 46. Global Classical Swine Fever Vaccines Revenue Share by Sales Channel (2016-2021)
    Table 47. Global Classical Swine Fever Vaccines Price (US$/K Doses) by Sales Channel (2016-2021)
    Table 48. WINSUN Corporation Information
    Table 49. WINSUN Description and Business Overview
    Table 50. WINSUN Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million US$), Price (US$/K Doses) and Gross Margin (2016-2021)
    Table 51. WINSUN Classical Swine Fever Vaccines Product
    Table 52. WINSUN Recent Developments/Updates
    Table 53. Merial Corporation Information
    Table 54. Merial Description and Business Overview
    Table 55. Merial Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million US$), Price (US$/K Doses) and Gross Margin (2016-2021)
    Table 56. Merial Classical Swine Fever Vaccines Product
    Table 57. Merial Recent Developments/Updates
    Table 58. CAHIC Corporation Information
    Table 59. CAHIC Description and Business Overview
    Table 60. CAHIC Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million US$), Price (US$/K Doses) and Gross Margin (2016-2021)
    Table 61. CAHIC Classical Swine Fever Vaccines Product
    Table 62. CAHIC Recent Developments/Updates
    Table 63. Chopper Biology Corporation Information
    Table 64. Chopper Biology Description and Business Overview
    Table 65. Chopper Biology Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million US$), Price (US$/K Doses) and Gross Margin (2016-2021)
    Table 66. Chopper Biology Classical Swine Fever Vaccines Product
    Table 67. Chopper Biology Recent Developments/Updates
    Table 68. MSD Animal Health (Merck) Corporation Information
    Table 69. MSD Animal Health (Merck) Description and Business Overview
    Table 70. MSD Animal Health (Merck) Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million US$), Price (US$/K Doses) and Gross Margin (2016-2021)
    Table 71. MSD Animal Health (Merck) Classical Swine Fever Vaccines Product
    Table 72. MSD Animal Health (Merck) Recent Developments/Updates
    Table 73. ChengDu Tecbond Corporation Information
    Table 74. ChengDu Tecbond Description and Business Overview
    Table 75. ChengDu Tecbond Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million US$), Price (US$/K Doses) and Gross Margin (2016-2021)
    Table 76. ChengDu Tecbond Classical Swine Fever Vaccines Product
    Table 77. ChengDu Tecbond Recent Developments/Updates
    Table 78. Ceva Corporation Information
    Table 79. Ceva Description and Business Overview
    Table 80. Ceva Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million US$), Price (US$/K Doses) and Gross Margin (2016-2021)
    Table 81. Ceva Classical Swine Fever Vaccines Product
    Table 82. Ceva Recent Developments/Updates
    Table 83. Harbin Veterinary Research Institute Corporation Information
    Table 84. Harbin Veterinary Research Institute Description and Business Overview
    Table 85. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million US$), Price (US$/K Doses) and Gross Margin (2016-2021)
    Table 86. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product
    Table 87. Harbin Veterinary Research Institute Recent Developments/Updates
    Table 88. Qilu Animal Health Products Factory Corporation Information
    Table 89. Qilu Animal Health Products Factory Description and Business Overview
    Table 90. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million US$), Price (US$/K Doses) and Gross Margin (2016-2021)
    Table 91. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product
    Table 92. Qilu Animal Health Products Factory Recent Developments/Updates
    Table 93. Ringpu Biology Corporation Information
    Table 94. Ringpu Biology Description and Business Overview
    Table 95. Ringpu Biology Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million US$), Price (US$/K Doses) and Gross Margin (2016-2021)
    Table 96. Ringpu Biology Classical Swine Fever Vaccines Product
    Table 97. Ringpu Biology Recent Developments/Updates
    Table 98. DHN Corporation Information
    Table 99. DHN Description and Business Overview
    Table 100. DHN Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million US$), Price (US$/K Doses) and Gross Margin (2016-2021)
    Table 101. DHN Classical Swine Fever Vaccines Product
    Table 102. DHN Recent Developments/Updates
    Table 103. CAVAC Corporation Information
    Table 104. CAVAC Description and Business Overview
    Table 105. CAVAC Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million US$), Price (US$/K Doses) and Gross Margin (2016-2021)
    Table 106. CAVAC Classical Swine Fever Vaccines Product
    Table 107. CAVAC Recent Developments/Updates
    Table 108. Komipharm Corporation Information
    Table 109. Komipharm Description and Business Overview
    Table 110. Komipharm Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million US$), Price (US$/K Doses) and Gross Margin (2016-2021)
    Table 111. Komipharm Classical Swine Fever Vaccines Product
    Table 112. Komipharm Recent Developments/Updates
    Table 113. Agrovet Corporation Information
    Table 114. Agrovet Description and Business Overview
    Table 115. Agrovet Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million US$), Price (US$/K Doses) and Gross Margin (2016-2021)
    Table 116. Agrovet Classical Swine Fever Vaccines Product
    Table 117. Agrovet Recent Developments/Updates
    Table 118. Bioveta Corporation Information
    Table 119. Bioveta Description and Business Overview
    Table 120. Bioveta Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million US$), Price (US$/K Doses) and Gross Margin (2016-2021)
    Table 121. Bioveta Classical Swine Fever Vaccines Product
    Table 122. Bioveta Recent Developments/Updates
    Table 123. Jinyu Bio-Technology Corporation Information
    Table 124. Jinyu Bio-Technology Description and Business Overview
    Table 125. Jinyu Bio-Technology Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million US$), Price (US$/K Doses) and Gross Margin (2016-2021)
    Table 126. Jinyu Bio-Technology Classical Swine Fever Vaccines Product
    Table 127. Jinyu Bio-Technology Recent Developments/Updates
    Table 128. Institutul Pasteur Corporation Information
    Table 129. Institutul Pasteur Description and Business Overview
    Table 130. Institutul Pasteur Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million US$), Price (US$/K Doses) and Gross Margin (2016-2021)
    Table 131. Institutul Pasteur Classical Swine Fever Vaccines Product
    Table 132. Institutul Pasteur Recent Developments/Updates
    Table 133. MVP Corporation Information
    Table 134. MVP Description and Business Overview
    Table 135. MVP Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million US$), Price (US$/K Doses) and Gross Margin (2016-2021)
    Table 136. MVP Classical Swine Fever Vaccines Product
    Table 137. MVP Recent Developments/Updates
    Table 138. Tecon Corporation Information
    Table 139. Tecon Description and Business Overview
    Table 140. Tecon Classical Swine Fever Vaccines Sales (M Doses), Revenue (Million US$), Price (US$/K Doses) and Gross Margin (2016-2021)
    Table 141. Tecon Classical Swine Fever Vaccines Product
    Table 142. Tecon Recent Developments/Updates
    Table 143. Production Base and Market Concentration Rate of Raw Material
    Table 144. Key Suppliers of Raw Materials
    Table 145. Classical Swine Fever Vaccines Distributors List
    Table 146. Classical Swine Fever Vaccines Customers List
    Table 147. Classical Swine Fever Vaccines Market Trends
    Table 148. Classical Swine Fever Vaccines Growth Drivers
    Table 149. Classical Swine Fever Vaccines Market Challenges
    Table 150. Classical Swine Fever Vaccines Market Restraints
    Table 151. Global Classical Swine Fever Vaccines Sales Forecast by Source (2022-2027) & (M Doses)
    Table 152. Global Classical Swine Fever Vaccines Sales Market Share Forecast by Source (2022-2027)
    Table 153. Global Classical Swine Fever Vaccines Revenue Forecast by Source (2022-2027) & (US$ Million)
    Table 154. Global Classical Swine Fever Vaccines Revenue Market Share Forecast by Source (2022-2027)
    Table 155. Global Classical Swine Fever Vaccines Sales Forecast by Sales Channel (2022-2027) & (M Doses)
    Table 156. Global Classical Swine Fever Vaccines Sales Market Share Forecast by Sales Channel (2022-2027)
    Table 157. Global Classical Swine Fever Vaccines Revenue Forecast by Sales Channel (2022-2027) & (US$ Million)
    Table 158. Global Classical Swine Fever Vaccines Revenue Market Share Forecast by Sales Channel (2022-2027)
    Table 159. Global Classical Swine Fever Vaccines Sales Forecast by Region (2022-2027) & (M Doses)
    Table 160. Global Classical Swine Fever Vaccines Sales Market Share Forecast by Region (2022-2027)
    Table 161. Global Classical Swine Fever Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 162. Global Classical Swine Fever Vaccines Revenue Market Share Forecast by Region (2022-2027)
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Classical Swine Fever Vaccines
    Figure 2. Global Classical Swine Fever Vaccines Market Share by Source in 2020 & 2027
    Figure 3. Tissue Culture Origin Product Picture
    Figure 4. Cell Line Origin Product Picture
    Figure 5. Global Classical Swine Fever Vaccines Market Share by Sales Channel in 2020 & 2027
    Figure 6. Government Tender
    Figure 7. Market Sales
    Figure 8. Global Classical Swine Fever Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 9. Global Classical Swine Fever Vaccines Market Size 2016-2027 (US$ Million)
    Figure 10. Global Classical Swine Fever Vaccines Sales 2016-2027 (M Doses)
    Figure 11. Global Classical Swine Fever Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 12. Classical Swine Fever Vaccines Sales Share by Manufacturers in 2020
    Figure 13. Global Classical Swine Fever Vaccines Revenue Share by Manufacturers in 2020
    Figure 14. The Global 5 and 10 Largest Classical Swine Fever Vaccines Players: Market Share by Revenue in 2020
    Figure 15. Classical Swine Fever Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 16. Global Classical Swine Fever Vaccines Sales Market Share by Region (2016-2021)
    Figure 17. Global Classical Swine Fever Vaccines Sales Market Share by Region in 2020
    Figure 18. Global Classical Swine Fever Vaccines Revenue Market Share by Region (2016-2021)
    Figure 19. Global Classical Swine Fever Vaccines Revenue Market Share by Region in 2020
    Figure 20. U.S. Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 21. Canada Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 22. Germany Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 23. France Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. U.K. Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. Italy Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. Russia Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. China Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. Japan Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. South Korea Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. India Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. Australia Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. Taiwan Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. Indonesia Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. Thailand Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. Malaysia Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Philippines Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Vietnam Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Mexico Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Brazil Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Argentina Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. Turkey Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Saudi Arabia Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. U.A.E Classical Swine Fever Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Sales Market Share of Classical Swine Fever Vaccines by Source (2016-2021)
    Figure 45. Sales Market Share of Classical Swine Fever Vaccines by Sales Channel (2016-2021)
    Figure 46. Sales Market Share of Classical Swine Fever Vaccines by Sales Channel in 2020
    Figure 47. Revenue Share of Classical Swine Fever Vaccines by Sales Channel (2016-2021)
    Figure 48. Revenue Share of Classical Swine Fever Vaccines by Sales Channel in 2020
    Figure 49. Manufacturing Cost Structure of Classical Swine Fever Vaccines
    Figure 50. Manufacturing Process Analysis of Classical Swine Fever Vaccines
    Figure 51. Classical Swine Fever Vaccines Industrial Chain Analysis
    Figure 52. Channels of Distribution
    Figure 53. Distributors Profiles
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user(purchaser of the report) to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Bacterial Vaginosis Drug Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-17B2476
Thu Jan 26 00:00:00 UTC 2023

Add to Cart

Global Human Oral Vaccine Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-10E12823
Thu Jan 12 00:00:00 UTC 2023

Add to Cart

Global Kennel Cough Treatment Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-36F12913
Thu Jan 12 00:00:00 UTC 2023

Add to Cart

Global Adult Chronic Hepatitis B Treatment Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-15A13061
Thu Jan 12 00:00:00 UTC 2023

Add to Cart